Lack of association between the 135G/C Rad51 gene polymorphism and the risk of colorectal cancer among polish population

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 84, Issue 7, 2012, Pages 358-362

  Mucha, Bartosz ^a   Przybyłowska Sygut, Karolina ^a   Dziki, Łukasz ^a   Dziki, Adam ^a   Sygut, Andrzej ^a   Majsterek, Ireneusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

135G C RAD51 gene; colorectal cancer; polymorphism

Indexed keywords

DNA BINDING PROTEIN; RAD51 PROTEIN; RAD51 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CELL TRANSFORMATION; COLORECTAL TUMOR; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLAND; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RAD51 RECOMBINASE; RISK FACTORS;

EID: 84866121054     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-012-0060-x     Document Type: Article

References (28)

1. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46(4): 765-81.
2. Parkin DM, Bray F, Ferlay J et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
3. Poynter JN, Gruber SB, Higgins PD et al.: Statins and the risk of colorectal cancer. N Engl J Med 2005; 352(21): 2184-92. (Pubitemid 40727085)
4. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999; 91(11): 916-32. (Pubitemid 29272518)
5. Weitz J, Koch M, Debus J et al.: Colorectal cancer. Lancet 2005; 365(9454): 153-65. (Pubitemid 40091806)
6. Elliott B, Jasin M: Double-strand breaks and translocations in cancer. Cell Mol Life Sci 2002; 59(2): 373-85.
7. Khanna KK, Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27(3): 247-54. (Pubitemid 32201842)
8. Harrison JC, Haber JE: Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 2006; 40: 209-35. (Pubitemid 44956785)
9. Johnson R, D, Jasin M: Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. The EMBO journal 2000; 19(13): 3398-3407. (Pubitemid 30428217)
10. Carreira A, Kowalczykowski SC: Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms. Proc Natl Acad Sci USA 2011; 108(26): 10448-53.
11. Li XHeyer WD: Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 2008; 18(1): 99-113.
12. Baumann P, West SC: Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci 1998; 23(7): 247-51. (Pubitemid 28343368)
13. San Filippo J, Sung P, Klein H: Mechanism of eukaryotic homologous recombination. Annu Rev Biochem 2008; 77: 229-57.
14. Schmutte C, Tombline G, Rhiem K et al.: Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH). Cancer Res 1999; 59(18): 4564-69. (Pubitemid 29428959)
15. Tsuzuki T, Fujii Y, Sakumi K et al.: Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA 1996; 93(13): 6236-40. (Pubitemid 26230288)
16. Wang WW, Spurdle AB, Kolachana P et al.: A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2001; 10(9): 955-60. (Pubitemid 32844903)
17. Hasselbach L, Haase S, Fischer D et al.: Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol 2005; 26(6): 589-98. (Pubitemid 43028049)
18. Zhou GW, Hu J, Peng XD et al.: RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2011; 125(2): 529-35.
19. Levy-Lahad E, Lahad A, Eisenberg S et al.: A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 2001; 98(6): 3232-36. (Pubitemid 32220828)
20. Helleday T: Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis 2010; 31(6): 955-60.
21. Gray NK: Translational control by repressor proteins binding to the 5'UTR of mRNAs. Methods Mol Biol 1998; 77: 379-97.
22. Arias-Lopez C, Lazaro-Trueba I, Kerr P et al.: p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep 2006; 7(2): 219-24.
23. Winiewska-Jarosiska M Liwinski T Krupa R et al. The role of RAD 51 gene polymorphism in patients with colorectal cancer in the Polish subpopulation, Pol Merkur Lekarski, 2009, 26, 155, 455-57
24. Krupa R, Sliwinski T, Wi?niewska-Jarosi?ska M et al.: Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer-A case control study. Mol Biol Rep 2011; 38(4): 2849-54.
25. Poplawski T, Arabski M, Kozirowska D et al.: DNA damage and repair in gastric cancer-A correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res 2006; 601(1-2): 83-91. (Pubitemid 44528596)
26. Jakubowska A, Gronwald J, Menkiszak J et al.: The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2007; 16(2): 270-75. (Pubitemid 46383345)
27. Rollinson S, Smith AG, Allan JM et al.: RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leuk Res 2007; 31(2): 169-74. (Pubitemid 44854198)
28. Fang F, Wang J, Yao L et al.: Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis. Medical oncology (Northwood, London, England), 2011; 28(4): 999-1003.